×
For best experience we recommend to activate Javascript in your browser.
Recombinant Peroxiredoxin 2 antibody
The Rabbit Monoclonal anti-Peroxiredoxin 2 antibody (Clone R02-1G5) (ABIN7516558) specifically detects Peroxiredoxin 2 in WB and IHC (p).
The antibody is reactive with Human samples.
Catalog No. ABIN7516558
$634.34
Plus shipping costs $50.00
Delivery in 11 to 14 Business Days
Quick Overview for Recombinant Peroxiredoxin 2 antibody (ABIN7516558)
Target
See all Peroxiredoxin 2 (PRDX2) Antibodies
Peroxiredoxin 2 (PRDX2)
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for Peroxiredoxin 2 antibodies
Human
Host
All hosts for Peroxiredoxin 2 antibodies
Rabbit
Clonality
All clonalities for Peroxiredoxin 2 antibodies
Monoclonal
Conjugate
All conjugates for Peroxiredoxin 2 antibodies
This Peroxiredoxin 2 antibody is un-conjugated
Application
All applications for Peroxiredoxin 2 antibodies
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Clone
R02-1G5
Product Details anti-Peroxiredoxin 2 Antibody
(hide)
Purpose
Rabbit recombinant monoclonal antibody raised against human PRDX2.
Cross-Reactivity
Human, Mouse, Rat
Immunogen
Original antibody is raised against a synthetic peptide corresponding to human PRDX2.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Immunohistochemistry (1:50-1:100),Western Blot (1:500-1:1000),The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
In 50 mM Tris-Glycine, pH 7.4 (0.15 M NaCl, 40 % Glycerol, 0.01 % Sodium azide and 0.05 % BSA).
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Store at -20 °C. Aliquot to avoid repeated freezing and thawing.
Target Details for Peroxiredoxin 2
(hide)
Target
Peroxiredoxin 2 (PRDX2)
Alternative Name
PRDX2
Background
Peroxiredoxin 2
Gene ID
7001
Recently viewed
(hide)
Chat with us , powered by LiveChat